Hemolytic Uremic Syndrome in a 65-Year-Old Male Linked to a Very Unusual Type of stx 2e- and eae-Harboring O51:H49 Shiga Toxin-Producing Escherichia coli
暂无分享,去创建一个
A. Mellmann | H. Hirsch | A. Egli | A. Fruth | R. Stephan | N. Khanna | C. Beckmann | H. Hächler | N. Cernela | D. Fasel | D. Goldenberger
[1] P. Tarr,et al. Therapy: Azithromycin and decolonization after HUS , 2012, Nature Reviews Nephrology.
[2] J. Blanco,et al. Seropathotypes, Phylogroups, Stx Subtypes, and Intimin Types of Wildlife-Carried, Shiga Toxin-Producing Escherichia coli Strains with the Same Characteristics as Human-Pathogenic Isolates , 2012, Applied and Environmental Microbiology.
[3] A. Mellmann,et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. , 2011, The Lancet. Infectious diseases.
[4] K. Jinneman,et al. Specificity of PCR and Serological Assays in the Detection of Escherichia coli Shiga Toxin Subtypes , 2011, Applied and Environmental Microbiology.
[5] A. Mellmann,et al. Phenotypic and genotypic traits of Shiga toxin-negative E. coli O157:H7/H(-) bovine and porcine strains. , 2009, Foodborne pathogens and disease.
[6] Lothar Beutin,et al. Characterization of attaching and effacing Escherichia coli (AEEC) isolated from pigs and sheep , 2008, BMC Microbiology.
[7] A. Mellmann,et al. Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.
[8] L. Beutin,et al. Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany , 2007, Journal of applied microbiology.
[9] F. Scheutz,et al. Subtyping Method for Escherichia coli Shiga Toxin (Verocytotoxin) 2 Variants and Correlations to Clinical Manifestations , 2007, Journal of Clinical Microbiology.
[10] R. Robins-Browne,et al. Atypical Enteropathogenic Escherichia coli Infection and Prolonged Diarrhea in Children , 2006, Emerging infectious diseases.
[11] A. Mellmann,et al. Shiga Toxin 2e-Producing Escherichia coli Isolates from Humans and Pigs Differ in Their Virulence Profiles and Interactions with Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.
[12] J. Wells,et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. , 2005, The Journal of infectious diseases.
[13] L. Beutin,et al. Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated from Human Patients in Germany over a 3-Year Period , 2004, Journal of Clinical Microbiology.
[14] A. Friedrich,et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.
[15] O. Clermont,et al. Rapid and Simple Determination of theEscherichia coli Phylogenetic Group , 2000, Applied and Environmental Microbiology.
[16] Craig S. Wong,et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.
[17] J. R. Johnson,et al. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. , 2000, The Journal of infectious diseases.
[18] James C. Paton,et al. Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections , 1998, Clinical Microbiology Reviews.
[19] H. Lior,et al. Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin , 1991, The Lancet.